Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0380
-0.0010 (-2.56%)
Sep 11, 2026, 3:44 PM NZST
Rua Bioscience Revenue
In the fiscal year ending June 30, 2026, Rua Bioscience had annual revenue of 2.92M NZD with 60.10% growth. Rua Bioscience had revenue of 1.46M in the half year ending December 31, 2025, with 929.17% growth.
Revenue
2.92M
Revenue Growth
+60.10%
P/S Ratio
4.41
Revenue / Employee
n/a
Employees
30
Market Cap
12.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 2.92M | 1.10M | 60.10% |
| Jun 30, 2025 | 1.83M | 1.51M | 477.39% |
| Jun 30, 2024 | 316.35K | -352.13K | -52.68% |
| Jun 30, 2023 | 668.48K | 23.39K | 3.63% |
| Jun 30, 2022 | 645.10K | 285.76K | 79.52% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EBOS Group | 16.43B |
| Fisher & Paykel Healthcare Corporation | 2.31B |
| Ryman Healthcare | 854.47M |
| Green Cross Health | 545.98M |
| Summerset Group Holdings | 388.36M |
| Radius Residential Care | 202.28M |
| Promisia Healthcare | 40.10M |
| Third Age Health Services | 22.49M |
Rua Bioscience News
- 6 months ago - Rua Bioscience Quarterly report: H1 2026 - Filings
- 6 months ago - Rua Bioscience Earnings release: H1 2026 - Filings
- 10 months ago - Rua Bioscience Transcript: AGM 2025 - Transcripts
- 10 months ago - Rua Bioscience Slides: FY 2025 - Filings
- 11 months ago - Rua Bioscience Annual report: H2 2025 - Filings
- 11 months ago - Rua Bioscience Earnings release: H2 2025 - Filings